Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 82

Related Articles by Review for PubMed (Select 15654123)

1.

High-level lipoprotein [a] expression in transgenic mice: evidence for oxidized phospholipids in lipoprotein [a] but not in low density lipoproteins.

Schneider M, Witztum JL, Young SG, Ludwig EH, Miller ER, Tsimikas S, Curtiss LK, Marcovina SM, Taylor JM, Lawn RM, Innerarity TL, Pitas RE.

J Lipid Res. 2005 Apr;46(4):769-78. Epub 2005 Jan 16.

2.

Transgenic rabbits expressing human apolipoprotein (a).

Fan J, Watanabe T.

J Atheroscler Thromb. 2000;7(1):8-13. Review.

PMID:
11425047
3.

The role of oxidized phospholipids in mediating lipoprotein(a) atherogenicity.

Tsimikas S, Witztum JL.

Curr Opin Lipidol. 2008 Aug;19(4):369-77. doi: 10.1097/MOL.0b013e328308b622. Review.

PMID:
18607184
4.

Transgenic mice expressing human apoB100 and apoB48.

Young SG, Farese RV Jr, Pierotti VR, Taylor S, Grass DS, Linton MF.

Curr Opin Lipidol. 1994 Apr;5(2):94-101. Review.

PMID:
8044422
5.

Lipoprotein(a) as a risk factor for atherosclerosis and thrombosis: mechanistic insights from animal models.

Boffa MB, Marcovina SM, Koschinsky ML.

Clin Biochem. 2004 May;37(5):333-43. Review.

PMID:
15087247
6.

[Lipoprotein Lp(a) and CETP (cholesterol ester transfer protein): contribution of transgenic mice].

Chapman J, Guérin M.

Bull Acad Natl Med. 1994 Mar;178(3):427-34; discussion 434-6. Review. French.

PMID:
8076182
7.

Lipids and progression of renal disease: role of modified low density lipoprotein and lipoprotein(a).

Wanner C, Greiber S, Krämer-Guth A, Heinloth A, Galle J.

Kidney Int Suppl. 1997 Dec;63:S102-6. Review.

PMID:
9407434
8.

New insights into the role of lipoprotein(a)-associated lipoprotein-associated phospholipase A2 in atherosclerosis and cardiovascular disease.

Tsimikas S, Tsironis LD, Tselepis AD.

Arterioscler Thromb Vasc Biol. 2007 Oct;27(10):2094-9. Epub 2007 Jul 12. Review.

9.

The role of lipoprotein-associated phospholipase A2 in atherosclerosis may depend on its lipoprotein carrier in plasma.

Tellis CC, Tselepis AD.

Biochim Biophys Acta. 2009 May;1791(5):327-38. doi: 10.1016/j.bbalip.2009.02.015. Review.

PMID:
19272461
10.

Lipoprotein (a).

Durrington PN.

Baillieres Clin Endocrinol Metab. 1995 Oct;9(4):773-95. Review.

PMID:
8593125
11.
12.

Structure and possible biological roles of Lp(a).

Karmansky I, Gruener N.

Clin Biochem. 1994 Jun;27(3):151-62. Review.

PMID:
7923754
13.
14.

Atherosclerosis: another protein misfolding disease?

Ursini F, Davies KJ, Maiorino M, Parasassi T, Sevanian A.

Trends Mol Med. 2002 Aug;8(8):370-4. Review.

PMID:
12127722
15.

Using genetically modified mice to study apolipoprotein B.

Young SG.

J Atheroscler Thromb. 1996;3(2):62-74. Review.

PMID:
9226457
16.

[Lipoprotein (a)].

Zlatohlávek L, Zídková K, Vrablík M.

Vnitr Lek. 2007 Apr;53(4):434-40. Review. Czech.

PMID:
17578180
17.

Dyslipidemia and nephrotic syndrome: recent advances.

Kronenberg F.

J Ren Nutr. 2005 Apr;15(2):195-203. Review.

PMID:
15827892
18.

Genetic basis and pathophysiological implications of high plasma Lp(a) levels.

Scanu AM.

J Intern Med. 1992 Jun;231(6):679-83. Review.

PMID:
1535652
20.

[Lipoprotein(a): a link between thrombosis and atherosclerosis?].

Hansen PR.

Ugeskr Laeger. 1993 May 17;155(20):1527-30. Review. Danish.

PMID:
8316983
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk